Search research articles
Contact Us
Filters
Showing results (31-40 of 47) with videos related to
Page
of 5
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 31, 1998
Cell surface density of p185(c-erbB-2) determines susceptibility to anti-p185(c-erbB-2)-ricin A chain (RTA) immunotoxin therapy alone and in combination with anti-p170(EGFR)-RTA in ovarian cancer cells
G S Dean, L Pusztai, F J Xu, et al.
International Journal of Cancer
|
January 15, 1989
Heterogeneity of antigen expression in benign and malignant breast and ovarian epithelial cells
C M Boyer, M J Borowitz, K S McCarty, et al.
Cancer
|
June 15, 1993
Serum levels of HER-2 neu (C-erbB-2) correlate with overexpression of p185neu in human ovarian cancer
S J McKenzie, K A DeSombre, B S Bast, et al.
Nuclear Medicine and Biology
|
July 1, 1997
Radioiodinated antibody targeting of the HER-2/neu oncoprotein
F J Xu, Y H Yu, D S Bae, et al.
Cancer
|
May 15, 1996
Expression of cell regulatory proteins in ovarian borderline tumors
C van Haaften-Day, P Russell, C M Boyer, et al.
Cancer Research
|
June 11, 1991
Cytotoxic T-lymphocytes derived from patients with breast adenocarcinoma recognize an epitope present on the protein core of a mucin molecule preferentially expressed by malignant cells
K R Jerome, D L Barnd, K M Bendt, et al.
Cancer Research
|
April 15, 1989
Immunohistochemical expression of CA 125 in endometrial adenocarcinoma: correlation of antigen expression with metastatic potential
A Berchuck, A P Soisson, D L Clarke-Pearson, et al.
International Journal of Cancer
|
October 15, 1994
The tyrosine kinase activity of the C-erbB-2 gene product (p185) is required for growth inhibition by anti-p185 antibodies but not for the cytotoxicity of an anti-p185-ricin-A chain immunotoxin
F J Xu, C M Boyer, D S Bae, et al.
International Journal of Cancer
|
July 9, 1992
A combination of two immunotoxins exerts synergistic cytotoxic activity against human breast-cancer cell lines
J R Crews, L A Maier, Y H Yu, et al.
Nature
|
August 18, 1994
Regulation of tumour necrosis factor-alpha processing by a metalloproteinase inhibitor
G M McGeehan, J D Becherer, R C Bast, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 47) with videos related to
Sort By:
Page
of 5
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 31, 1998
Cell surface density of p185(c-erbB-2) determines susceptibility to anti-p185(c-erbB-2)-ricin A chain (RTA) immunotoxin therapy alone and in combination with anti-p170(EGFR)-RTA in ovarian cancer cells
G S Dean, L Pusztai, F J Xu, et al.
International Journal of Cancer
|
January 15, 1989
Heterogeneity of antigen expression in benign and malignant breast and ovarian epithelial cells
C M Boyer, M J Borowitz, K S McCarty, et al.
Cancer
|
June 15, 1993
Serum levels of HER-2 neu (C-erbB-2) correlate with overexpression of p185neu in human ovarian cancer
S J McKenzie, K A DeSombre, B S Bast, et al.
Nuclear Medicine and Biology
|
July 1, 1997
Radioiodinated antibody targeting of the HER-2/neu oncoprotein
F J Xu, Y H Yu, D S Bae, et al.
Cancer
|
May 15, 1996
Expression of cell regulatory proteins in ovarian borderline tumors
C van Haaften-Day, P Russell, C M Boyer, et al.
Cancer Research
|
June 11, 1991
Cytotoxic T-lymphocytes derived from patients with breast adenocarcinoma recognize an epitope present on the protein core of a mucin molecule preferentially expressed by malignant cells
K R Jerome, D L Barnd, K M Bendt, et al.
Cancer Research
|
April 15, 1989
Immunohistochemical expression of CA 125 in endometrial adenocarcinoma: correlation of antigen expression with metastatic potential
A Berchuck, A P Soisson, D L Clarke-Pearson, et al.
International Journal of Cancer
|
October 15, 1994
The tyrosine kinase activity of the C-erbB-2 gene product (p185) is required for growth inhibition by anti-p185 antibodies but not for the cytotoxicity of an anti-p185-ricin-A chain immunotoxin
F J Xu, C M Boyer, D S Bae, et al.
International Journal of Cancer
|
July 9, 1992
A combination of two immunotoxins exerts synergistic cytotoxic activity against human breast-cancer cell lines
J R Crews, L A Maier, Y H Yu, et al.
Nature
|
August 18, 1994
Regulation of tumour necrosis factor-alpha processing by a metalloproteinase inhibitor
G M McGeehan, J D Becherer, R C Bast, et al.
Page
of 5